Biotech Catalyst Daily · Archive
Every past edition. New briefings publish every weekday by 7:00 AM Eastern.
- Apr 17, 2026 UCB Acquires Neurona for Up to $1.2B to Enhance Epilepsy Pipeline UCB's acquisition of Neurona marks a strategic move into cell therapy for epilepsy.
- Apr 12, 2026 FDA Rejects Replimune's Melanoma Drug for Second Time Replimune faces regulatory challenges as FDA denies melanoma treatment again.